Both in Pharmaceuticals
Olema Pharmaceuticals vs Geron
Over the past year OLMA returned −12.7% and GERN returned −22.5%; their daily moves had a correlation of 0.08.
OLMA −12.7% GERN −22.5%Growth of $1, one year, split-adjusted
| Metric | OLMA | GERN |
|---|---|---|
| Price | $7.35 | $0.9300 |
| Market cap | $643.1M | $597.5M |
| Today | +3.96% | +0.10% |
| 1 month | −10.9% | −23.1% |
| 6 months | −49.8% | −43.6% |
| Year to date | −70.6% | −29.5% |
| 1 year | −18.1% | −26.2% |
| Revenue growth (YoY) | — | +17.2% |
| Gross margin | — | 83.9% |
| Net margin | — | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.9× |
| Net cash | $458.1M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 60.6% | 60.0% |
| Short % of float | 24.8% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).